BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$297.43
+$3.73(+1.27%)
44
Overall
50
Value
25
Tech
57
Quality
Market Cap
$8.03B
Volume
159.00K
52W Range
$211.43 - $358.40
Target Price
$352.50

Company Overview

Mkt Cap$8.03BPrice$297.43
Volume159.00KChange+1.27%
P/E Ratio-4.4Open$289.11
Revenue$2.6BPrev Close$293.70
Net Income$-1.8B52W Range$211.43 - $358.40
Div YieldN/ATarget$352.50
Overall44Value50
Quality57Technical25

No chart data available

About Bio-Rad Laboratories Inc. Class A

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Biome Australia Secures Ethics Approval for First Human Trial of Proprietary Probiotic BMB18

Biome Australia Ltd ( ($AU:BIO) ) has issued an update. Biome Australia has received ethics approval from La Trobe University’s Human Research Ethi...

TipRanks Australian Auto-Generated Newsdesk20 hours ago

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Danaher (DHR) and BridgeBio Pharma (BBIO)

Brian Andersona day ago

Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Zenas BioPharma, Inc. (ZBIO)

Catie Powers4 days ago

Sabio Wins WorkLife Award Honors and Hires Atrium for Sponsored Research Coverage

TipRanks Canadian Auto-Generated Newsdesk6 days ago

Berenberg Bank Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)

TipRanks Auto-Generated Intelligence Newsdesk11 days ago
ABCD
1SymbolPriceChangeVol
2BIO$297.43+1.3%159.00K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.